Janux Total Assets from 2010 to 2024

JANX Stock

USD 46.39 1.61 3.35%

Janux Therapeutics Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 251.1 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

380.4 M

Current Value

251.1 M

Quarterly Volatility

159.1 M

Credit Downgrade

Yuan Drop

Covid

Check Janux Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Janux Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 13.1 M, Depreciation And Amortization of 2.1 M or Interest Expense of 4.9 M, as well as many indicators such as Price To Sales Ratio of 55.51, Dividend Yield of 0.0 or PTB Ratio of 1.44. Janux financial statements analysis is a perfect complement when working with Janux Therapeutics Valuation or Volatility modules.

Check out the analysis of Janux Therapeutics Correlation against competitors.

For more information on how to buy Janux Stock please use our How to Invest in Janux Therapeutics guide.

Latest Janux Therapeutics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Janux Therapeutics over the last few years. Total assets refers to the total amount of Janux Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Janux Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Janux Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Janux Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 380.41 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Janux Total Assets Regression Statistics

	Arithmetic Mean	93,219,876
	Geometric Mean	4,398,368
	Coefficient Of Variation	170.68
	Mean Deviation	133,654,885
	Median	679,000
	Standard Deviation	159,109,942
	Sample Variance	25316T
	Range	379.7M
	R-Value	0.74
	Mean Square Error	12175.4T
	R-Squared	0.55
	Significance	0
	Slope	26,467,196
	Total Sum of Squares	354423.6T

Janux Total Assets History

	2024	251.1 M
	2023	380.4 M
	2022	364 M
	2021	379.8 M
	2020	16.2 M

Other Fundumenentals of Janux Therapeutics

Intangibles To Total Assets

Janux Therapeutics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Current Deferred Revenue	Capital Surpluse
Total Assets		1.0	0.97	-0.63	-0.84	1.0	0.74	1.0	-0.48	1.0	1.0	1.0	-0.81	1.0	0.83	0.73	0.68
Total Stockholder Equity	1.0		0.97	-0.64	-0.83	1.0	0.7	1.0	-0.47	1.0	1.0	1.0	-0.79	1.0	0.81	0.74	0.67
Net Tangible Assets	0.97	0.97		-0.52	-0.9	0.97	0.72	0.97	-0.66	0.97	0.97	0.97	-0.8	0.97	0.89	0.67	0.74
Net Debt	-0.63	-0.64	-0.52		0.16	-0.62	-0.38	-0.63	-0.22	-0.65	-0.59	-0.65	0.66	-0.59	-0.19	-0.92	0.12
Retained Earnings	-0.84	-0.83	-0.9	0.16		-0.84	-0.81	-0.83	0.82	-0.83	-0.86	-0.83	0.67	-0.86	-0.99	-0.37	-0.93
Accounts Payable	1.0	1.0	0.97	-0.62	-0.84		0.73	1.0	-0.5	1.0	1.0	1.0	-0.82	1.0	0.82	0.72	0.69
Total Liab	0.74	0.7	0.72	-0.38	-0.81	0.73		0.7	-0.48	0.72	0.75	0.72	-0.78	0.75	0.84	0.46	0.69
Net Invested Capital	1.0	1.0	0.97	-0.63	-0.83	1.0	0.7		-0.47	1.0	1.0	1.0	-0.79	1.0	0.81	0.74	0.67
Short Long Term Debt	-0.48	-0.47	-0.66	-0.22	0.82	-0.5	-0.48	-0.47		-0.47	-0.5	-0.48	0.44	-0.5	-0.79	-0.01	-0.81
Total Current Assets	1.0	1.0	0.97	-0.65	-0.83	1.0	0.72	1.0	-0.47		1.0	1.0	-0.81	1.0	0.81	0.74	0.66
Capital Stock	1.0	1.0	0.97	-0.59	-0.86	1.0	0.75	1.0	-0.5	1.0		1.0	-0.78	1.0	0.85	0.7	0.71
Net Working Capital	1.0	1.0	0.97	-0.65	-0.83	1.0	0.72	1.0	-0.48	1.0	1.0		-0.82	1.0	0.81	0.74	0.66
Short Term Debt	-0.81	-0.79	-0.8	0.66	0.67	-0.82	-0.78	-0.79	0.44	-0.81	-0.78	-0.82		-0.78	-0.64	-0.62	-0.49
Common Stock	1.0	1.0	0.97	-0.59	-0.86	1.0	0.75	1.0	-0.5	1.0	1.0	1.0	-0.78		0.85	0.7	0.71
Property Plant Equipment	0.83	0.81	0.89	-0.19	-0.99	0.82	0.84	0.81	-0.79	0.81	0.85	0.81	-0.64	0.85		0.42	0.89
Current Deferred Revenue	0.73	0.74	0.67	-0.92	-0.37	0.72	0.46	0.74	-0.01	0.74	0.7	0.74	-0.62	0.7	0.42		0.04
Capital Surpluse	0.68	0.67	0.74	0.12	-0.93	0.69	0.69	0.67	-0.81	0.66	0.71	0.66	-0.49	0.71	0.89	0.04

Click cells to compare fundamentals

About Janux Therapeutics Financial Statements

Janux Therapeutics investors use historical fundamental indicators, such as Janux Therapeutics' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Janux Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	380.4 M	251.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Janux Stock Analysis

When running Janux Therapeutics' price analysis, check to measure Janux Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Janux Therapeutics is operating at the current time. Most of Janux Therapeutics' value examination focuses on studying past and present price action to predict the probability of Janux Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Janux Therapeutics' price. Additionally, you may evaluate how the addition of Janux Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC